Ranexa
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Extended-release ranolazine (ranolazine ER) (Ranexa) is an antianginal agent that achieves its effects via a novel mechanism of…
We report the case of a renal transplant patient on tacrolimus who developed a fully reversible renal failure and a doubling in…
Ranolazine [Ranexa; (±)-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine] is novel anti-ischemic…
Ranolazine will provide a small benefit in symptom control in patients with chronic angina and persistent symptoms despite…
(1) Ranolazine-- an adjunctive treatment to beta-blockers, calcium channel blockers, or long-acting nitrates-- is indicated for…
CV Therapeutics, under license from Roche (formerly Syntex), is developing ranolazine (Ranexa), a metabolic modulator and a…